CRO-67

N/A

Report date: 2023/12/15 15:42:29
NME

Base Information

Drug NameCRO-67
Drug Alias NameDual-Cell Therapy(Noxopharm)CRO-67
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNoxopharm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNoxopharm Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A